Holger Petering

716 total citations
18 papers, 558 citations indexed

About

Holger Petering is a scholar working on Oncology, Physiology and Immunology. According to data from OpenAlex, Holger Petering has authored 18 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Physiology and 7 papers in Immunology. Recurrent topics in Holger Petering's work include Asthma and respiratory diseases (9 papers), Chemokine receptors and signaling (7 papers) and Immune Cell Function and Interaction (6 papers). Holger Petering is often cited by papers focused on Asthma and respiratory diseases (9 papers), Chemokine receptors and signaling (7 papers) and Immune Cell Function and Interaction (6 papers). Holger Petering collaborates with scholars based in Germany, Austria and Switzerland. Holger Petering's co-authors include Alexander Kapp, Jörn Elsner, Daniela Kimmig, Regina Smolarski, Otto Götze, Renate Höchstetter, Timothy N. C. Wells, Thomas Werfel, Paul Ponath and Rudolf Herbst and has published in prestigious journals such as Blood, The Journal of Immunology and Journal of Bacteriology.

In The Last Decade

Holger Petering

17 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger Petering Germany 13 289 209 159 93 83 18 558
Daniela Kimmig Germany 12 430 1.5× 346 1.7× 257 1.6× 35 0.4× 121 1.5× 15 703
Jayendra Kumar Krishnaswamy United States 14 546 1.9× 132 0.6× 77 0.5× 109 1.2× 54 0.7× 22 798
Monika Kapińska-Mrowiecka Poland 12 299 1.0× 86 0.4× 51 0.3× 108 1.2× 82 1.0× 29 553
Bryan S. Clay United States 15 619 2.1× 211 1.0× 100 0.6× 43 0.5× 93 1.1× 21 922
Yukinori Tanaka Japan 14 265 0.9× 106 0.5× 101 0.6× 51 0.5× 79 1.0× 36 615
Sandra Holzmann Austria 8 710 2.5× 78 0.4× 176 1.1× 112 1.2× 75 0.9× 8 910
Kunio Sano Japan 12 421 1.5× 221 1.1× 39 0.2× 48 0.5× 132 1.6× 22 632
Kota Kokubo Japan 13 300 1.0× 151 0.7× 51 0.3× 43 0.5× 75 0.9× 20 593
Karen Buckland United Kingdom 12 483 1.7× 375 1.8× 70 0.4× 57 0.6× 220 2.7× 24 851
Yoshiki Tokura Japan 15 544 1.9× 54 0.3× 211 1.3× 292 3.1× 101 1.2× 28 925

Countries citing papers authored by Holger Petering

Since Specialization
Citations

This map shows the geographic impact of Holger Petering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Petering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Petering more than expected).

Fields of papers citing papers by Holger Petering

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Petering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Petering. The network helps show where Holger Petering may publish in the future.

Co-authorship network of co-authors of Holger Petering

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Petering. A scholar is included among the top collaborators of Holger Petering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Petering. Holger Petering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Reinhold, Uwe, Holger Petering, Thomas Dirschka, et al.. (2018). Photodynamic therapy with a 5‐ALA patch does not increase the risk of conversion of actinic keratoses into squamous cell carcinoma. Experimental Dermatology. 27(12). 1399–1402. 7 indexed citations
2.
Philipp‐Dormston, Wolfgang G., Sigrid Karrer, Holger Petering, et al.. (2015). MAL‐PDT mit Tageslicht – Aktuelle Datenlage und praxisorientierte Empfehlungen eines Expertentreffens. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 13(12). 1240–1249. 1 indexed citations
3.
Philipp‐Dormston, Wolfgang G., Sigrid Karrer, Holger Petering, et al.. (2015). Daylight PDT with MAL – current data and practical recommendations of an expert panel. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 13(12). 1240–1249. 15 indexed citations
4.
Raap, Ulrike, Holger Petering, Takashi Hashimoto, et al.. (2004). Erfolgreiche Therapie des IgA-Pemphigus vom subkorneal pustul�sen Typ. Der Hautarzt. 56(1). 66–70. 2 indexed citations
5.
Petering, Holger, et al.. (2003). Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. Journal of the American Academy of Dermatology. 50(1). 68–72. 45 indexed citations
6.
Petering, Holger, et al.. (2001). Characterization of the CC Chemokine Receptor 3 on Human Keratinocytes. Journal of Investigative Dermatology. 116(4). 549–555. 26 indexed citations
7.
Petering, Holger, Patrick J. Kiel, Christian Breuer, Alexander Kapp, & Thomas Werfel. (2001). Pyoderma gangraenosum. Der Hautarzt. 52(1). 47–50. 20 indexed citations
8.
Elsner, J., et al.. (2000). Ultrarush SIT in venom allergy. Allergy. 55(6). 582–583. 6 indexed citations
9.
Petering, Holger, Jörg Köhl, Daniela Kimmig, et al.. (2000). Characterization of Synthetic C3a Analog Peptides on Human Eosinophils in Comparison to the Native Complement Component C3a. The Journal of Immunology. 164(7). 3783–3789. 19 indexed citations
10.
Elsner, Jörn, Holger Petering, Daniela Kimmig, et al.. (1999). The CC Chemokine Receptor Antagonist Met–RANTES Inhibits Eosinophil Effector Functions. International Archives of Allergy and Immunology. 118(2-4). 462–465. 30 indexed citations
11.
Petering, Holger, Otto Götze, Daniela Kimmig, et al.. (1999). The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils. Blood. 93(2). 694–702. 72 indexed citations
12.
Petering, Holger, Otto Götze, Daniela Kimmig, et al.. (1999). The Biologic Role of Interleukin-8: Functional Analysis and Expression of CXCR1 and CXCR2 on Human Eosinophils. Blood. 93(2). 694–702. 83 indexed citations
13.
Petering, Holger, Renate Höchstetter, Daniela Kimmig, et al.. (1998). Cutting Edge: Detection of MCP-4 in Dermal Fibroblasts and Its Activation of the Respiratory Burst in Human Eosinophils. The Journal of Immunology. 160(2). 555–558. 30 indexed citations
14.
Elsner, Jörn, Holger Petering, Daniela Kimmig, et al.. (1998). Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. European Journal of Immunology. 28(7). 2152–2158. 47 indexed citations
15.
Petering, Holger, Renate Höchstetter, Daniela Kimmig, et al.. (1998). Detection of MCP-4 in dermal fibroblasts and its activation of the respiratory burst in human eosinophils.. PubMed. 160(2). 555–8. 37 indexed citations
16.
Elsner, Jörn, Holger Petering, Daniela Kimmig, et al.. (1998). Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils. European Journal of Immunology. 28(7). 2152–2158. 1 indexed citations
17.
Elsner, Jörn, Holger Petering, Renate Höchstetter, et al.. (1997). The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. European Journal of Immunology. 27(11). 2892–2898. 94 indexed citations
18.
Petering, Holger, Sven Hammerschmidt, Matthias Frosch, et al.. (1996). Genes associated with meningococcal capsule complex are also found in Neisseria gonorrhoeae. Journal of Bacteriology. 178(11). 3342–3345. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Kimmig Breakdown of academic impact, for papers by Jayendra Kumar Krishnaswamy Breakdown of academic impact, for papers by Monika Kapińska-Mrowiecka Breakdown of academic impact, for papers by Bryan S. Clay Breakdown of academic impact, for papers by Yukinori Tanaka Breakdown of academic impact, for papers by Sandra Holzmann Breakdown of academic impact, for papers by Kunio Sano Breakdown of academic impact, for papers by Kota Kokubo Breakdown of academic impact, for papers by Karen Buckland Breakdown of academic impact, for papers by Yoshiki Tokura
Rankless by CCL
2026